| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Veeva Reiterates Quarterly and Annual Guidance
Veeva is reiterating the following financial guidance issued on the Company's earnings call on February 29, 2024:
For the quarter ending April 30, 2024:
| · | Total Revenue: $640-643 million |
| · | Non-GAAP Operating Income: $245-247 million |
For the fiscal year ending January 31, 2025:
| · | Total Revenue: $2,725-2,740 million |
| · | Non-GAAP Operating Income: ~$1,070 million |
The information in this Item 7.01 of this Current Report on Form 8-K shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended (the "Securities Act"), or the Exchange Act, regardless of any general incorporation language in such filing, unless expressly incorporated by reference in such filing.
Veeva is not able, at this time, to provide GAAP targets for operating income for the first fiscal quarter ending April 30, 2024, or fiscal year ending January 31, 2025, because of the difficulty of estimating certain items excluded from non-GAAP operating income that cannot be reasonably predicted, such as charges related to stock-based compensation expense. The effect of these excluded items may be significant.
Posted In: VEEV
